facebook

Compound Everyday PMS

PMS Rating

IME PMS Rating

AMC does not meet our selection criteria at this time

Not a Recommended AMC: Compound Everyday PMS is still very early in its journey and has yet to scale beyond its original focus of managing money for a private group of friends & family. The 1-star rating of the AMC is primarily driven by the AMC still being sub-scale. Since the firm is still sub-scale, we have not done additional evaluations with regards the AMC Pedigree, Investment Philosophy, Team & Performance.

The PMS/AIF AMC Rating is derived on the basis of our analysis on 5 key qualitative parameters that we use to analyse the quality of a PMS/AIF Provider. These include an assessment of the size of the AMC, the pedigree of the AMC, the pedigree of the team, the value of the investment philosophy & the level of differentiation. These insights of our central research team are documented in the IME RMS, and can be accessed during a consultation call with an IME PMS specialist.

PMS Background

Discretionary AUM (30cr) | Promoter Category ()

PMS Background

Compound Everyday was founded in 2012 as a value oriented multifamily investment office catering to a private group of family and friends, and got their PMS license in 2019.

PMS Investment Philosophy

Compound Everyday follows a value-oriented investment philosophy.

Inv Team

Investment Team

Sumit Sarda | 2-star rated FM

Founder & Portfolio Manager | 15 yrs Experience | 5 yrs at current firm

Past Experience: EA to Chairman (ENAM), Investment Banking (JP Morgan)

Sumit Sarda has 10+ years of investments experience, the most noteable of which was working as an Executive Assistant to Vallabh Bhansali (one of the most prominent figures in the Indian investments business).

PMS/AIF Schemes

PMS & Listed Equity AIF Schemes

Returns as of 31-May-24.

Free 30-Day Trial of the IME RMS

Details shared above, are only a short-snapshot of the more detailed analysis that resides in IME’s Proprietary RMS (Research Management Solution).

The IME RMS is the first tool ever, to give investors direct access to the insights of the central research team. Investors gain direct access to our ratings, rating rationales & analysis across thousands of funds (MFs, PMSs, AIFs, Global funds), asset classes, categories & more.

 Learn More